Skip to main content

Market Access Monitor

Service of monitoring key reimbursement and HTA developments for medical devices, in-vitro diagnostic tests, and digital technologies in Europe and globally

Learn more
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

Bi-weekly snapshot of market access and HEOR project work at MTRC

Our goal at MTRC is to inform the decision-making of our clients and to support their market access activities. Below is a snapshot of our planned activities for the next two weeks. This can help our existing and prospective clients understand the potential scope of our support better.

From the week of October 06th, we are planning to work on 20 projects, including:

Reimbursement

  1. Working on market access strategy for the administration of a medication in outpatient settings in England, France, Germany, and Sweden
  2. Working on reimbursement analysis for molecular diagnostic technologies in 12 European countries
  3. Working on market size analysis for neurovascular technologies in eight European countries
  4. Working on reimbursement analysis for medical aids used in the urology area in France, Germany, and Italy
  5. Working on reimbursement analysis for medical aids used in the gastrointestinal area in France, Germany, and Italy
  6. Working on reimbursement analysis for cardiac devices in 10 European countries
  7. Working on reimbursement analysis for a minimally invasive orthopedic procedure in France
  8. Working on reimbursement analysis for an implantable device in the urology area in England, France, Germany, and Spain
  9. Working on reimbursement analysis for a medical device used in gastrointestinal surgery in Belgium, England, France, and Italy 
  10. Working on reimbursement analysis for a diagnostic test for infectious diseases in England, France, Germany, Italy, and Spain
  11. Working on reimbursement analysis for diagnostic imaging procedures in the cardiovascular area in 11 European countries
  12. Initiating work on reimbursement analysis for home-based in-vitro diagnostic tests in nine European countries 
  13. Initiating work on reimbursement analysis for cancer treatment in Italy and Turkey 

HEOR

  1. Working on the development of a health economic model for in-vitro diagnostic tests in neurology disease areas in England, France, Germany, Italy, and Spain 
  2. Working on a systematic review and meta-analysis for an in vitro diagnostic test
  3. Working on a clinical value dossier for an in vitro diagnostic test in the neurology area 
  4. Working on a systematic literature review update for a minimally invasive technology in the neurology area
  5. Working on evidence gap analysis for medical aids used in the urology area in France and Germany
  6. Working on evidence gap analysis for medical aids used in the gastrointestinal area in France and Germany
  7. Working on evidence gap analysis for a minimally invasive orthopedic procedure in France 

Let us know if you need any market access or HEOR support for your medical technology in Europe.